Personalised immunotherapy can keep disease at bay for more than four years
Copy link
Personalised immunotherapy can keep disease at bay for more than four years
Personalised immunotherapy can keep disease at bay for more than four years
Copy link

Thousands of men with prostate cancer facing unnecessary overtreatment, experts warn

‘Remarkable’ pancreatic cancer jab offers longer survival hope for patients

Thousands more prostate cancer patients could avoid overtreatment

Men being over-treated for prostate cancer, says charity